The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections.

Diagnostic accuracy has improved with the use of newer technologies that can further classify cancers and identify specific genes, proteins, and genetic mutations or alterations that drive tumor growth.

For example, experts at MSK have developed a genome-sequencing test that allows our doctors to quickly find out whether a patient’s tumor carries mutations that could aid in treatment and to match individual patients with available therapies or clinical trials that will most benefit them.

The test, called MSK-IMPACT™, allows for the comprehensive molecular analysis of cells from any type of solid tumor, regardless of where in the body the cancer is thought to have arisen. MSK researchers recently worked with a biotech company to co-develop a similar genomic test to identify genetic alterations in blood cancers.

Results of these types of tests may be listed on your pathology report or made available to you in a separate report.

On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.

Regards,

Robert Solomon

Editorial office

Journal of Clinical and Experimental Pathology

E-mail: pathol@eclinicalsci.com

Reach Us: +1-947-333-4405